Virtus ETF Advisers’s Enliven Therapeutics ELVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-3,091
Closed -$69.5K 399
2024
Q4
$69.5K Sell
3,091
-1,097
-26% -$24.7K 0.03% 380
2024
Q3
$107K Buy
4,188
+77
+2% +$1.97K 0.05% 367
2024
Q2
$96.1K Buy
+4,111
New +$96.1K 0.05% 335